# IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine

> **NCT02664116** · PHASE4 · UNKNOWN · sponsor: **Scripps Health** · enrollment: 40 (estimated)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** Diclofenac postassium powder for oral solution and placebo injection
- **DRUG:** Ketorolac intramuscular injection and placebo oral solution

## Key facts

- **NCT ID:** NCT02664116
- **Lead sponsor:** Scripps Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2017-07
- **Final completion:** 2017-07
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-02-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02664116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02664116, "IM Ketorolac vs Cambia for the Acute Treatment of Severe Migraine". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02664116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*